Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
W. Don Cornwell
AddedFeb 19, 2024
UpdatedMay 31, 2026
W. Don Cornwell

W. Don Cornwell

Board Member, Amer.Intl GRP NEW DL 2 50

The Org

W. Don Cornwell's Career

Amer.Intl GRP NEW DL 2 50
Amer.Intl GRP NEW DL 2 50

New York City, NY, US

Board Member· Board
Pfizer
Pfizer

New York, NY, US

Board Member· Board
Viatris
Viatris

Canonsburg, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

W. Don Cornwell's Career

Amer.Intl GRP NEW DL 2 50
Amer.Intl GRP NEW DL 2 50
Investment FirmInvestment Firm26.2k1919New York City, NY, US
Board Member· Board

Leadership at Amer.Intl GRP NEW DL 2 50

John RiceJohn RiceBoard Member
Tom MotamedTom MotamedBoard Member
Terri VaughanTerri VaughanBoard Member
Linda MillsLinda MillsBoard Member
William JurgensenWilliam JurgensenBoard Member
Peter ZaffinoPeter ZaffinoBoard Member
Pfizer
Pfizer
Public$31B83k1849New York City, NY, US
Board Member· Board

Recent news

Promise Bio exits stealth backed by Pfizer and AstraZenecaTechCrunch · 2024
Nigeria’s Remedial Health gets QED backing in $12M roundTechCrunch · 2023

Leadership at Pfizer

Sarah M. WilliamsSarah M. WilliamsCo-Founder
Sue Desmond-HellmannSue Desmond-HellmannBoard Member
Suhas PrabhuSuhas PrabhuBoard Member
Scott GottliebScott GottliebBoard Member
Ian ReadIan ReadBoard Member
Albert BourlaAlbert BourlaBoard Member

Similar to Pfizer

Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
ViatrisViatrisCanonsburg, PA, USPharmaceuticalsest. 2020ViatrisCanonsburg, PA, US · est. 2020

Viatris Inc.: A global healthcare company producing pharmaceuticals for a wide range of diseases worldwide.

Public37k
SanofiSanofiParis, Paris, FRPharmaceuticalsest. 1973SanofiParis, Paris, FR · est. 1973

Sanofi, a global French pharmaceutical firm, manufactures prescription drugs and vaccines, specializing in various medical fields.

Public · $610M91.6k
Bayer PharmaceuticalsBayer PharmaceuticalsBerlin, Berlin, DEDrugs, Pharmaceuticalsest. 2003Bayer PharmaceuticalsBerlin, Berlin, DE · est. 2003

Bayer Pharmaceuticals: A global enterprise specializing in biochemical research and drug manufacturing since 2008.

Public10k
Viatris
Viatris
Public37k2020Canonsburg, PA, US
Board Member· Board

Leadership at Viatris

Mark ParrishMark ParrishBoard Member
Scott A. SmithScott A. SmithBoard Member
Robert J. CouryRobert J. CouryBoard Member
JoEllen Lyons DillonJoEllen Lyons DillonBoard Member
Rajiv MalikRajiv MalikBoard Member

W. Don Cornwell's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to W. Don Cornwell

Neil DimickNeil DimickBoard Member · Resources ConnectionTimothy P. FlynnTimothy P. FlynnBoard Member · JPMorgan Chase